0.14Open0.14Pre Close0 Volume131 Open Interest103.00Strike Price0.00Turnover115.56%IV25.11%PremiumAug 30, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.14Extrinsic Value100Contract SizeAmericanOptions Type0.0469Delta0.0093Gamma422.77Leverage Ratio-0.1014Theta0.0004Rho19.84Eff Leverage0.0089Vega
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.